CSL Behring is a global biotechnology company that specializes in the development and production of innovative therapies for rare and serious diseases. The CSL Behring Recombinant Facility AG is dedicated to the production of recombinant proteins for use in therapeutic applications. The facility is equipped with state-of-the-art technology and employs a team of highly skilled professionals to ensure the highest quality products. With a focus on research and development, CSL Behring continues to push the boundaries of medicine to improve the lives of patients around the world.
This text is generated by artificial intelligence and may not be accurate.